Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain

Summary

The purpose of the study is to test the efficacy of ATNC05 in the treatment of Atypical Facial Pain (AFP), also known as Persistent Idiopathic Facial Pain (PIFP). This research project targets patients with chronic constant facial pain and excludes patients with primarily paroxysmal pain.

Timeline

Start

2014-03

Primary completion

2016-03

Completion

2016-07

Drugs

Indications